about
Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.Magnesium deficiency and oxidative stress: an update.Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.Serum Magnesium Concentrations in the Canadian Population and Associations with Diabetes, Glycemic Regulation, and Insulin ResistanceEffects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials.Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes.Clinical aspects of magnesium physiology in patients on dialysis.Prevention and Therapy of Type 2 Diabetes-What Is the Potential of Daily Water Intake and Its Mineral Nutrients?Nutrition, inflammation and liver-spleen axis.Serum magnesium and the risk of prediabetes: a population-based cohort study.The Central Role of Biometals Maintains Oxidative Balance in the Context of Metabolic and Neurodegenerative Disorders.Frequency of Type-2 diabetes mellitus in Nephropathic patients and comparison of mean magnesium levels in Nephropathic patients with and without Type-2 diabetes mellitus.Magnesium intake and mortality due to liver diseases: Results from the Third National Health and Nutrition Examination Survey Cohort.Magnesium Intake, Quality of Carbohydrates, and Risk of Type 2 Diabetes: Results From Three U.S. Cohorts.Dietary Magnesium and Cardiovascular Disease: A Review with Emphasis in Epidemiological Studies.Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank Project.Higher Dietary Magnesium Intake and Higher Magnesium Status Are Associated with Lower Prevalence of Coronary Heart Disease in Patients with Type 2 Diabetes.Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms.Healthy ageing: the natural consequences of good nutrition-a conference report.SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.Electrolyte and Acid-Base Disorders in the Renal Transplant RecipientHypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation
P2860
Q33845734-138B2FBE-718F-4981-8892-8F1A92D0E617Q37418565-B9A84B39-6EA8-41F2-8249-BB54853D29A7Q37673143-C0CA4563-7E2F-4594-BB9A-DDF271202323Q37729871-AC8A70EF-DD73-4E1B-AF01-14F13F218972Q37737458-052FBDB8-3899-4664-B575-4D3A4EA8CE5DQ39039079-F5812D2E-87D4-45C7-922F-86C54B57AFF2Q39369171-1714C801-884A-4AF1-A331-85B1FBCC7660Q40075512-AACA628A-7305-416F-BCCC-09A6C651DA92Q40086170-1CA782FC-F790-49A0-8E36-4BF56B071877Q40324557-0A6956C3-E9AB-4F3F-9788-821490BD2625Q41023080-EA52F821-2B83-4019-A2D3-7153D5BFA045Q45913764-6AED248F-6411-4D9C-B63E-888EBD4C2FF2Q47179866-853BD0A1-F79E-423D-B026-FB2741D32F5CQ48052466-49924EC5-1E1F-4D97-84F7-F38774BC34EBQ48124288-0654DF99-7B72-42B3-B311-F5DA49E96626Q52591396-52C47F4D-767E-4617-AA38-7DF261819356Q55345494-2EA1E6D1-0072-42C7-9DA5-E4441F07A720Q55358122-AAA0AC48-F1E9-4BA7-A3A2-2FE4BDC0B2A4Q55383174-B28BBDFC-8085-4356-ABA3-75BBA6EE8FEAQ55411384-14D73A5C-21CE-4D03-9DB7-52B50F06655CQ58586519-8FA3E63F-FE0D-4FBC-B8E1-645DF4E6EC7FQ58803514-29B39C57-ABCE-4BBD-840A-70DD7DE0CB0D
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?
@ast
Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?
@en
Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?
@nl
type
label
Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?
@ast
Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?
@en
Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?
@nl
prefLabel
Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?
@ast
Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?
@en
Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?
@nl
P2093
P356
P1433
P1476
Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?
@en
P2093
Joost G J Hoenderop
Lisanne M M Gommers
René J M Bindels
P356
10.2337/DB15-1028
P407
P577
2016-01-01T00:00:00Z